Status:

UNKNOWN

Cryoneurolysis for Cutaneous Neuropathic Pain

Lead Sponsor:

Aarhus University Hospital

Conditions:

Neuropathic Pain

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Feasibility study with 25 patients investigating the effect of cryoneurolysis on persistent cutaneous neuropathic pain after surgery and trauma. All patients receive active treatment (cryoneurolysis)....

Eligibility Criteria

Inclusion

  • Age \> 17 years
  • ASA (American Society of Anesthesiologists) physical status classification system I-III
  • Informed consent
  • Capable of subjective evaluation of pain
  • Capable of reading and understanding Danish and informed written consent
  • Average pain intensity \>49/100 on VAS in the primary focal pain area for a minimum of 6 months at the time of inclusion
  • Relevant injury (surgery or trauma) of peripheral nerves
  • Plausible cutaneous location of pain
  • In the area of pain, at least one of the following (1-8): (1) Hypo/anesthesia for touch/brush (2) Hypo/anesthesia for cold (3) Hypo/anesthesia for warmth (4) Hypo/anesthesia for pinprick (5) Allodynia for touch/brush (6) Allodynia for cold (7) Allodynia for warmth (8) Hyperalgesia for pinprick
  • Neuropathic pain score (Douleur Neuropathique en 4 Questions, DN-4) \>3/10
  • Definitive diagnosis of neuropathic pain (Finnerup et al 2016)

Exclusion

  • Inability to cooperate
  • Inability to understand Danish
  • Allergy to local anesthetic
  • Infection in the area of cryo probe insertion
  • Significant competitive chronic pain
  • Progressive neurologic disease
  • Increased risk at needle insertion and cold exposure (e.g. Raynaud, coagulopathies)
  • Uncontrolled severe systemic disease
  • Implanted electronic devices unless approved by the relevant medical specialist
  • Previous cryoneurolysis with no relevant effect for the same neuropathic pain
  • Previous interventional pain therapy (e.g. spinal cord stimulation) with no relevant effect for the same neuropathic pain
  • Expected duration of life \< 2 years
  • Pregnancy
  • Abuse of alcohol, narcotics or medicine
  • Current psychiatric disease
  • Inclusion in other clinical trials
  • Ongoing patient complaint
  • Body mass index \< 18.5 or \> 34.9 kg/m2
  • Change of pain therapy within the last 28 days prior to inclusion

Key Trial Info

Start Date :

June 7 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2023

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT04911569

Start Date

June 7 2021

End Date

January 1 2023

Last Update

June 3 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Aarhus University Hospital

Aarhus, Central Jutland, Denmark, 8000